Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 26, 2016 - Issue 7
Submit an article Journal homepage
123
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Therapeutic polymeric nanoparticles and the methods of making and using thereof: a patent evaluation of WO2015036792

Sailu SarvagallaCentre for Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Puducherry, India
,
Hsing Pang HsiehInstitute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan, ROC
&
Mohane Selvaraj CoumarCentre for Bioinformatics, School of Life Sciences, Pondicherry University, Kalapet, Puducherry, IndiaCorrespondence[email protected]
Pages 751-755 | Received 04 Jan 2016, Accepted 09 May 2016, Published online: 24 May 2016

References

  • Kollareddy M, Dzubak P, Zheleva D, et al. Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152(1):27–33.
  • Hochegger H, Hegarat N, Pereira-Leal JB. Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle. Open Biol. 2013;3(3):120185.
  • Sarvagalla S, Coumar MS. Structural biology insight for the design of sub-type selective aurora kinase inhibitors. Curr Cancer Drug Targets. 2015;15(5):375–393.
  • Carmena M, Earnshaw WC, Glover DM. The dawn of aurora kinase research: from fly genetics to the clinic. Front Cell Dev Biol. 2015;3:73.
  • Cheung CH, Coumar MS, Hsieh HP, et al. Aurora kinase inhibitors in preclinical and clinical testing. Expert Opin Investig Drugs. 2009;18(4):379–398.
  • Cheung CH, Sarvagalla S, Lee JY, et al. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011-2013). Expert Opin Ther Pat. 2014;24(9):1021–1038.
  • Wissing MD, van Diest PJ, van der Wall E, et al. Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer. Expert Opin Investig Drugs. 2013;22(5):635–661.
  • Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C Mater Biol Appl. 2016;60:569–578.
  • Zhu Y, Liao L. Applications of nanoparticles for anticancer drug delivery: a review. J Nanosci Nanotechnol. 2015;15(7):4753–4773.
  • Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci. 2011;36(7):887–913.
  • Elsabahy M, Heo GS, Lim S-M, et al. Polymeric nanostructures for imaging and therapy. Chem Rev. 2015;115(19):10967–11011.
  • Ganoth A, Merimi KC, Peer D. Overcoming multidrug resistance with nanomedicines. Expert Opin Drug Deliv. 2015;12(2):223–238.
  • Wang Y, Wei X, Zhang C, et al. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Ther Deliv. 2010;1(2):273–287.
  • Prados J, Melguizo C, Ortiz R, et al. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem. 2012;12(9):1058–1070.
  • Dawidczyk CM, Kim C, Park JH, et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release. 2014;187:133–144.
  • Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134.
  • Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release. 2007;117(2):163–170.
  • Kantarjian HM, Martinelli G, Jabbour EJ, et al. Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia. Cancer. 2013;119(14):2611–2619.
  • AstraZeneca. Phosphonooxy quinazoline derivatives and their pharmaceutical use WO2004058781. 2004.
  • Wilkinson RW, Odedra R, Heaton SP, et al. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin Cancer Res. 2007;13(12):3682–3688.
  • Pluim D, Beijnen JH, Schellens JH, et al. Simultaneous determination of AZD1152 (prodrug) and AZD1152-hydroxyquinazoline pyrazol anilide by reversed phase liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(29):3549–3555.
  • Lowenberg B, Muus P, Ossenkoppele G, et al. Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia. Blood. 2011;118(23):6030–6036.
  • AstraZeneca. Therapeutic polymeric nanoparticles and methods of making and using same WO2015036792. 2015.
  • Kollareddy M, Zheleva D, Dzubak P, et al. Aurora kinase inhibitors: progress towards the clinic. Invest New Drugs. 2012;30(6):2411–2432.
  • Farag SS. The potential role of Aurora kinase inhibitors in haematological malignancies. Br J Haematol. 2011;155(5):561–579.
  • Ashton S, Song YH, Nolan J, et al. Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo. Sci Transl Med. 2016;8(325):325ra17.
  • Bearss DJ. Are accurins the cure for Aurora kinase inhibitors? Sci Transl Med. 2016;8(325):325fs4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.